Dr. Reddy's to Conduct Human Trial for Sputnik V COVID-19 Vaccine in India, an Industrial Info Market Brief
Indian pharmaceutical major Dr. Reddy's Laboratories Limited is set to begin human clinical trials in India for the Sputnik V vaccine, which is being developed by the Gamaleya National Research Institute of Epidemiology & Microbiology in Russia.
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
